506414 — Fermenta Biotech Balance Sheet
0.000.00%
- IN₹10.56bn
- IN₹10.95bn
- IN₹4.69bn
- 88
- 34
- 80
- 79
Annual balance sheet for Fermenta Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 444 | 335 | 605 | 597 | 715 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 805 | 959 | 566 | 866 | 1,278 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 3,096 | 3,140 | 2,530 | 2,418 | 3,352 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 2,194 | 2,373 | 2,585 | 2,535 | 2,322 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 6,871 | 7,068 | 6,358 | 5,478 | 6,145 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2,093 | 2,071 | 2,087 | 1,733 | 2,119 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 3,265 | 3,347 | 3,212 | 2,590 | 2,518 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 3,606 | 3,721 | 3,146 | 2,889 | 3,627 |
Total Liabilities & Shareholders' Equity | 6,871 | 7,068 | 6,358 | 5,478 | 6,145 |
Total Common Shares Outstanding |